[1] Holmes D. Repairing the neural highway. Nature. 2017;552(7684): S50-S51.[2] Barber PC, Lindsay RM. Schwann cells of the olfactory nerves contain glial fibrillary acidic protein and resemble astrocytes. Neuroscience. 1982;7(12):3077-3090.[3] Ranmón-Cueto A, Valverde F. Olfactory bulb ensheathing glia: a unique cell type with axonal growth-promoting properties. Glia. 1995; 14(3):163-173.[4] Doucette R. Glial influences on axonal growth in the primary olfactory system. Glia.2010;3(6):433-449.[5] 朱海涛,朱悦,孙德日. 嗅鞘细胞抑制脊髓损伤后硫酸软骨素蛋白聚糖表达的实验研究[J]. 中国医科大学学报, 2007, 36(3):244-246.[6] Doucette R. Glial cells in the nerve fiber layer of the main olfactory bulb of embryonic and adult mammals. Microsc Res Tech. 1993; 24(2):113-130.[7] Khankan RR, Griffis KG, Haggerty-Skeans JR, et al. Olfactory Ensheathing Cell Transplantation after a Complete Spinal Cord Transection Mediates Neuroprotective and Immunomodulatory Mechanisms to Facilitate Regeneration. J Neurosci. 2016;36(23): 6269-6286.[8] Pérez-Bouza A, Wigley CB, Nacimiento W, et al. Spontaneous orientation of transplanted olfactory glia influences axonal regeneration. Neuroreport.1998;9(13):2971-2975.[9] Ranmón-Cueto A, Cordero M I, Santosbenito F F, et al. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron. 2000; 25(2): 425-435.[10] Féron F, Perry C, Cochrane J, et al.Autologous olfactory ensheathing cell transplantation in human spinal cord injury.Brain. 2005;128(Pt 12):2951-2960.[11] Lima C, Escada P, Pratas-Vital J,, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair. 2010;24(1):10-22.[12] Li L, Adnan H, Xu B, et al. Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis. Eur Spine J. 2015;24(5):919-930.[13] Huang H, Chen L, Wang H, et al.Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury.Chin Med J (Engl). 2003; 116(10): 1488-1491[14] Zheng Z, Liu C, Zhang L, et al. Olfactory ensheathing cell transplantation in 106 patients with old spinal cord injury Differences in ages, sexes, disease courses, injured types and sites. Neural Regen Res.2007;2(6):380-384.[15] Wu J, Sun T, Ye C, et al. Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury. Cell Transplantation. 2012;21 Suppl 1(1):S33-7.[16] 张磊,郑遵成,刘超,等.嗅鞘细胞移植部位与剂量的选择对陈旧性脊髓损伤患者60例神经恢复的影响[J].中国民康医学,2008, 20(9): 870-871.[17] 刘超,郑遵成,高瑞,等. 嗅鞘细胞移植术后脊髓损伤患者功能的评价[J]. 中国组织工程研究与临床康复, 2008,12(16):3037-3040.[18] 郑遵成,刘超,高瑞,等.移植时间对嗅鞘细胞移植治疗脊髓损伤效果的影响[J]. 中国组织工程研究与临床康复, 2008,12(3):583-586.[19] Zheng Z, Liu G, Chen Y, et al.Olfactory ensheathing cell transplantation improves sympathetic skin responses in chronic spinal cord injury.Neural Regen Res.2013;8(30):2849-2855.[20] 黄红云,王洪美,陈琳,等. 胚胎嗅鞘细胞移植治疗晚期脊髓损伤影响功能恢复的因素[J]. 中国修复重建外科杂志, 2006,20(4):434-438.[21] 黄红云,陈琳,王洪美,等.嗅鞘细胞移植改善晚期脊髓损伤患者神经功能的近期效应[J]. 中国临床康复,2006,10(13):190-192.[22] Chen L, Huang H, Xi H, et al. A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries. Cell Transplantation. 2014;23 Suppl 1:S35.[23] 保国锋,崔志明,李卫东,等. 嗅鞘细胞移植治疗脊髓损伤5例报告[J].中国组织工程研究与临床康复,2007,11(3):512-514.[24] Huang H, Chen L, Xi H, et al. [Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009; 23(23):14-20.[25] Wang D, He X, Li H, et al. Five years follow-up observation on patients with spinal cord injury treated with olfactory ensheathing cell transplantation. J Investigative Med. 2013:S5-S6.[26] Huang H, Xi H, Chen L, et al. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.Cell Transplantation.2012;21 Suppl 1(1):S23.[27] Rao Y, Zhu W, Guo Y, et al. Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury. Cell Transplantation. 2013;22(1): S21-S25.[28] Lima C, Pratas-Vital J, Escada P, et al.Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study.J Spinal Cord Med. 2006;29(3):191-203. [29] Mackay-Sim A, Féron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain.2008;131(Pt 9): 2376-2386.[30] Tabakow P, Jarmundowicz W, Czapiga B, et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplantation.2013; 22(9):1591-1612.[31] 张志成,孙天胜,叶超群,等. 胸脊柱脊髓损伤的治疗[J]. 中国康复理论与实践, 2006, 12(4):336-338.[32] Rao Y, Zhu W, Liu H, et al. Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury. J Int Med Res. 2013;41(2):473-481.[33] Rao YJ, Zhu WX, Du ZQ, et al. Effectiveness of olfactory ensheathing cell transplantation for treatment of spinal cord injury. Genet Mol Res. 2014;13(2):4124-4129.[34] Hagell P, Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol. 2001;60(8):741-752.[35] Kordower JH, Styren S, Clarke M, et al. Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplantation. 1997; 6(3):213.[36] Louveau A, Smirnov I, Keyes TJ, et al.Structural and functional features of central nervous system lymphatic vessels. Nature. 2015,523(7560):337-341[37] 陈琳,方明俊,黄红云,等.人胚胎嗅鞘细胞移植供、受者HLA配型方法介绍[J].中国医疗前沿,2009,4(22):20-20.[38] Xiao J, Chen L, Mao G, et al. Neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells. J Neurorestoratol,2017; 5:175-179.[39] Nakhjavan-Shahraki B; Yousefifard M; Rahimi-Movaghar V, et al.Transplantation of olfactory ensheathing cells on functional recovery and neuropathic pain after spinal cord injury; systematic review and meta-analysis.Sci Rep.2018;8(1):325[40] Jiang Y, Zhu J, Xu G; et al.Intranasal delivery of stem cells to the brain.Expert Opin Drug Deliv.2011;8(5):623-32[41] Ninomiya K, Iwatsuki K, Ohnishi Y, et al.Intranasal delivery of bone marrow stromal cells to spinal cord lesions.J Neurosurg Spine.2015;23(1):111-119[42] Nijboer CH; Kooijman E, van Velthoven CT, et al. Intranasal Stem Cell Treatment as a Novel Therapy for Subarachnoid Hemorrhage. Stem Cells Dev.2018;27(5):313-325[43] Salama M, Sobh M, Emam M, et al.Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease. Exp Ther Med. 2017;13(3):976-982[44] Assinck P, Duncan GJ, Hilton BJ, et al.Cell transplantation therapy for spinal cord injury.Nat Neurosci. 2017;20(5):637-647. |